Benjamin D. Moncarz is the FDA’s Chief Financial Officer and is responsible for the administration’s comprehensive budget, acquisitions, financial management, planning and program evaluation, and enterprise risk management operations. As the FDA’s CFO, Mr. Moncarz has purview over five executive led offices, and a financial management and contracts portfolio that executes more than $6 billion annually.
Prior to joining the FDA, Mr. Moncarz served as Deputy CFO at the Federal Emergency Management Agency. While there, Mr. Moncarz served as the Acting CFO, spearheading FEMA’s financial leadership of COVID-19 pandemic response operations. Under his leadership, the FEMA team:
- Deployed thousands of staff to support tribal nations, and state, local, and territorial governments.
- Delivered 5.6 million vaccinations at FEMA Pilot Community Vaccination Centers across 26 states.
- Supported more than 1,300 vaccination sites nationwide.
- Obligated over $100 billion from the Disaster Relief Fund in support of the nationwide pandemic response.
Prior to becoming FEMA’s Deputy CFO, he was the agency’s Assistant Administrator for Budget. In this role he provided leadership and oversight for the agency’s budget formulation, execution, analysis, and reporting.
This included, serving as Chief of the Resource Support Section in the National Response Coordination Center during major disasters, including executive-level leadership in support of Hurricanes Harvey, Irma and Maria.
Mr. Moncarz holds a Bachelor of the Arts in Economics from Duke University and a Master’s Certificate in Project Management from George Washington University.